Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01531686 · ClinicalTrials.gov registry record
Observational Study of CT Dye Administration Through the Intraosseous Vascular Access Route
A clinical trial, sponsored by Vidacare Corporation.
- Terminated
- Registry status
- 8
- Enrollment target
NCT01531686: Clinical Trial study, sponsored by Vidacare Corporation.
NCT01531686 is a clinical trial that was terminated before completion, run by Vidacare Corporation. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01531686 was terminated before completion, sponsored by Vidacare Corporation.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
An observational study to determine the safety and effectiveness of Intraosseous (IO) vascular access for delivery of contrast dye for Computed Tomography (CT) examination. The hypothesis is that IO access can be safely and effectively used to deliver contrast medium for CT examination.
Primary Outcome
Adequacy of CT image graded as adequate or inadequate indicating the ability to effectively administer the contrast medium needed for the indicated CT examination.
Interventions
- PROCEDURE Intraosseous delivery of CT contrast dye
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-01 |
Why NCT01531686 stopped before completion
NCT01531686 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Intraosseous delivery of CT contrast dye is the first listed.
NCT01531686 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01531686 about?
NCT01531686 is a clinical study titled "Observational Study of CT Dye Administration Through the Intraosseous Vascular Access Route". An observational study to determine the safety and effectiveness of Intraosseous (IO) vascular access for delivery of contrast dye for Computed Tomography (CT) examination. The hypothesis is that IO access can be safely and effectively used to deliver contrast medium for CT examination.
What is the current status of trial NCT01531686?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2012-03. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01531686?
The interventions under investigation include: Intraosseous delivery of CT contrast dye (PROCEDURE).
Who is sponsoring clinical trial NCT01531686?
This trial is sponsored by Vidacare Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia